Corey Cleland
Primary Care · Sevierville, TNNPI 1760938047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 486 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 486 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$840
- GSK$653
- AstraZeneca$604
- Bayer$548
- Amarin Pharma, Inc.$540
- plus $4K from 32 others
What the payments were for
- Food & beverage$8,54999%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 91 | $1,321 |
| AbbVie | 66 | $840 |
| GSK | 37 | $653 |
| AstraZeneca | 30 | $604 |
| Bayer | 32 | $548 |
| Amarin Pharma, Inc. | 32 | $540 |
| Mannkind Corporation | 22 | $388 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $362 |
| Biohaven Pharmaceuticals, Inc. | 17 | $343 |
| Dexcom, Inc. | 15 | $307 |
| Corcept Therapeutics | 13 | $289 |
| Lilly USA, LLC | 17 | $281 |
| Cequr Corporation | 1 | $245 |
| Boehringer Ingelheim | 14 | $228 |
| Zealand Pharma US, Inc. | 7 | $191 |
| Medtronic | 8 | $176 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $156 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $140 |
| Astellas Pharma US Inc | 2 | $117 |
| Pfizer | 6 | $111 |
| Azurity Pharmaceuticals, Inc. | 5 | $108 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Arbor Pharmaceuticals, Inc. | 4 | $74 |
| Abbott | 3 | $66 |
| Merck | 3 | $56 |
| Evoke Pharma, Inc. | 2 | $42 |
| Novartis | 2 | $37 |
| Amgen(2 entities) | 3 | $37 |
| Ascensia Diabetes Care US Inc. | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Tandem Diabetes Care, Inc. | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$245
- CAPLYTA$125
- Kerendia$114
- NURTEC ODT$113
How this compares
$8,644 in reported general payments places this provider in the 95th percentile of 189 primary care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 195 | $283,488 |
| MounjaroTirzepatide | 101 | $140,911 |
| FarxigaDapagliflozin Propanediol | 92 | $119,122 |
| JardianceEmpagliflozin | 89 | $102,236 |
| EliquisApixaban | 66 | $74,949 |
| Nurtec OdtRimegepant Sulfate | 48 | $72,931 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 77 | $70,293 |
| Dimethyl Fumarate | 11 | $45,452 |
| AfrezzaInsulin Regular, Human | 21 | $41,668 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 63 | $39,061 |
| VascepaIcosapent Ethyl | 51 | $38,024 |
| JanuviaSitagliptin Phosphate | 35 | $35,811 |
| LinzessLinaclotide | 33 | $28,270 |
| Tresiba Flextouch U-100Insulin Degludec | 34 | $28,137 |
| XareltoRivaroxaban | 27 | $26,578 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $1,321 | $312,873224 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $281 | $173,822152 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $604 | $158,196174 claims |
| PfizerEliquis, Nurtec Odt | $111 | $147,879114 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $228 | $110,213105 claims |
| GSKTrelegy Ellipta | $653 | $70,29377 claims |
| AbbVieLinzess, Vraylar | $840 | $53,03749 claims |
| MerckJanuvia, Janumet | $56 | $42,71947 claims |
| Mannkind CorporationAfrezza | $388 | $41,66821 claims |
| BayerKerendia | $548 | $8,61313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 189 primary care providers in Tennessee.
Other primary care in Sevierville
- Mary SullivanGermantown$115K
- Len GetzMemphis$25K
- Judith CaldwellNashville$18K
- Mara HutchingsNashville$14K
- Reena BhaktaMurfreesboro$12K
- Ryan HartmanNashville$11K
- Martha LemonsBrentwood$11K
- Abigail EubankHendersonville$9K
- Katie JohnsonClarksville$8K
- Janice BassManchester$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.